Evidence map›Paper›PMID 39599495›Full record

ArticlePathogens (Basel, Switzerland)2024

Exploring Condition-Specific Variability in the Ureteral Stent Microbiome.

Ava Mousavi, Karan N Thaker, James E Ackerman, Niccole Diaz, Rick Martin, Craig D Tipton, Nick Tallman, Lina Marcella Henao, Nima Nassiri, Jeffrey Veale and 2 more

Abstract read
In one paragraph

Article in Pathogens (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Ava MousaviDepartment of Urology, UCLA David Geffen School of Medicine, Los Angeles, CA 90095, USA.
Karan N ThakerDepartment of Urology, UCLA David Geffen School of Medicine, Los Angeles, CA 90095, USA.ORCID 0000-0002-8451-1240
James E AckermanDepartment of Urology, UCLA David Geffen School of Medicine, Los Angeles, CA 90095, USA.
Niccole DiazMicroGen DX, Lubbock, TX 79407, USA.
Rick MartinMicroGen DX, Lubbock, TX 79407, USA.
Craig D TiptonMicroGen DX, Lubbock, TX 79407, USA.
Nick TallmanMicroGen DX, Lubbock, TX 79407, USA.
Lina Marcella HenaoDepartment of Urology, UCLA David Geffen School of Medicine, Los Angeles, CA 90095, USA.
Nima NassiriDepartment of Urology, UCLA David Geffen School of Medicine, Los Angeles, CA 90095, USA.
Jeffrey VealeDepartment of Urology, UCLA David Geffen School of Medicine, Los Angeles, CA 90095, USA.
Anne Lenore AckermanDepartment of Urology, UCLA David Geffen School of Medicine, Los Angeles, CA 90095, USA.ORCID 0000-0003-4192-7649
Kymora B ScotlandDepartment of Urology, UCLA David Geffen School of Medicine, Los Angeles, CA 90095, USA.ORCID 0000-0003-0749-3859

Funding

The Effect of Nanoparticle Encapsulated Resveratrol on Treatment of PeriodontitisKL2TR001882 · NCATS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI Elizabeta Nemeth · 2016 to 2026
$13.1M
NCATS NIH HHS KL2 TR001882UCLA Innovation Award N/AUrology Care Foundation Medical Student Fellowship Grant N/AViola Hyde Surgical Research Scholarship N/A
6 · The paper itself

Abstract

(1) Background: Indwelling ureteral stents are commonly used urological devices to maintain ureteral patency, yet they have been associated with complications such as infections. Some studies have shown that bacteria adhere to and create an antimicrobial-resistant biofilm on stents. One factor that may impact biofilm formation is the original condition informing stent placement, such as kidney stones and renal allografts. Both kidney stones and renal allografts are independently associated with infection, yet the differential stent microbiomes of these populations remain poorly characterized. Our objective was to characterize these microbiomes in order to inform urological health practice and help prevent ureteral stent-associated infections. (2) Methods: Stents were collected from kidney stone and renal transplant recipients undergoing routine cystoscopic stent removal. Microbial DNA was extracted from stents and analyzed using 16S Next Generation Sequencing. Descriptive statistics, alpha diversity, and beta diversity methods were used for statistical analysis. (3) Results: The microbiome of ureteral stents in kidney stone and transplant patients is composed of unique species, each with different biofilm-forming abilities. (4) Conclusions: Our findings demonstrate that the microbiome of stents differs based on preceding condition. It is important to conduct future studies that explore this microbiome further to understand what type of stent-associated infection someone may develop based on their initial condition.

Indexed as

BiofilmsKidney TransplantationMicrobiotaStentsUreterAdultAgedBacteriaFemaleHumansKidney CalculiMaleMiddle Agedstent infectionstent microbiomeureteral stent

Identifiers

PMID39599495
PMCPMC11597399

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.